A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer
Clinical trial NCT03086369 · COMPLETED
Trial details
- NCT number
- NCT03086369
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-22
- Primary completion
- 2021-01-05
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.